Skip to Content

Maviret 100 mg / 40 mg film-coated tablets

Licence status
Authorised: 26/07/2017
Active substances
Pibrentasvir, Glecaprevir
Dosage Form
Film-coated tablet
Licence number
EU/1/17/1213/001
Licence holder
AbbVie Deutschland GmbH & Co. KG

Licence information

ATC code
J05AX Other antivirals
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/07/2017